High-Resolution Detection of Cancer-Associated Structural Variants Using Electronic Genome Mapping

The OhmX Platform is advancing the detection of cancer-associated structural variants (SVs) with its high-resolution electronic genome mapping (EGM) capabilities. This application note highlights the platform's ability to accurately identify TP53 deletions and PML::RARA translocations in cancer cell lines. The study demonstrates how EGM's high tag density and resolution enable precise mapping of SVs, offering valuable insights for clinical oncology research.

By utilizing the OhmX Platform, you can achieve genome-wide coverage and detect key pathogenic events with unparalleled precision. The platform's cost-effective nature makes it an indispensable tool for high-resolution SV detection, supporting advancements in cancer research and treatment.

Download the application note to explore how the OhmX Platform can enhance your SV analysis and drive discovery in cancer genomics.